M. Gompels

发表

Joint longitudinal hurdle and time-to-event models: an application related to viral load and duration of the first treatment regimen in HIV patients initiating therapy.

K. Abrams, M. May, S. Brilleman, 2016 .

TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy

M. García-Fiñana, R. Kolamunnage-Dona, C. Leen, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Authors' response to Drs Scourfield, Jackson and Nelson

B. Gazzard, C. Leen, C. Sabin, 2011 .

Trends in HIV testing in the UK primary care setting: a 15-year retrospective cohort study from 2000 to 2015

J. Macleod, M. May, M. Gompels, 2019, BMJ Open.

Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy.

Delpech, B. Gazzard, C. Leen, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study

D. Podzamczer, B. Clotet, A. Winston, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

B. Gazzard, C. Leen, C. Sabin, 2011, BMJ : British Medical Journal.

Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count

B. Gazzard, C. Leen, D. Pillay, 2007, AIDS.

C1 inhibitor deficiency: management

M. Gompels, R. J. Lock, 2005, Clinical and experimental dermatology.

Joint longitudinal hurdle and time‐to‐event models: an application related to viral load and duration of the first treatment regimen in patients with HIV initiating therapy

Keith R Abrams, Michael J Crowther, Margaret T May, 2016, Statistics in medicine.

Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters

B. Gazzard, C. Leen, C. Sabin, 2011, HIV medicine.

Use and Effectiveness of HIV Indicator Conditions in Guiding HIV Testing: A Review of the Evidence

M. May, M. Gompels, C. Davies, 2017 .

Proposed use of adrenaline (epinephrine) in anaphylaxis and related conditions: a study of senior house officers starting accident and emergency posts

M. Gompels, S. Johnston, C. Bethune, 2002, Postgraduate medical journal.

CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK

B. Gazzard, C. Leen, D. Pillay, 2009, Haematologica.

CYP2B6 G516T genotyping in a UK cohort of HIV‐positive patients: polymorphism frequency and influence on efavirenz discontinuation

M. Gompels, V. Powers, J. Ward, 2009, HIV medicine.

Human papillomavirus type 16 and Kaposi's sarcoma

M. Gompels, A. Pinching, J. Boyd, 1992, The Lancet.

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

B. Gazzard, C. Leen, B. Yip, 2017, HIV medicine.

Lower Healthcare Costs Associated with the Use of a Single-Pill ARV Regimen in the UK, 2004–2008

B. Gazzard, R. Brettle, M. Youle, 2012, PloS one.

Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006

B. Gazzard, R. Brettle, M. Youle, 2011, PloS one.

The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996–2008

B. Gazzard, R. Brettle, M. Youle, 2011, PloS one.

Virological response to initial antiretroviral regimens containing abacavir or tenofovir.

B. Gazzard, C. Leen, D. Pillay, 2009, The Journal of infectious diseases.

C1 inhibitor deficiency: consensus document

M. Gompels, G. Davies, H. Longhurst, 2005, Clinical and experimental immunology.

Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?

B. Gazzard, C. Leen, C. Sabin, 2009, AIDS.

Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV.

H. Stellbrink, M. Johnson, E. Martinez, 2021, The Journal of antimicrobial chemotherapy.

Physiological effects of starvation interpreted as food allergy

M. Gompels, G. Spickett, C. Bethune, 1999, BMJ.

British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.

Smita Y. Patel, A. Nicholson, Smita Y Patel, 2017, The journal of allergy and clinical immunology. In practice.

Peripheral B Cell Deficiency and Predisposition to Viral Infections: The Paradigm of Immune Deficiencies

M. Gompels, S. Johnston, A. Grammatikos, 2021, Frontiers in Immunology.

Disseminated strongyloidiasis in AIDS: uncommon but important.

M. Gompels, B. Peters, A. Pinching, 1991, AIDS.

Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin

S. Stewart, M. Gompels, B. Peters, 1992, AIDS.

Correct recognition and management of anaphylaxis: not much change over a decade

M. Gompels, P. Bright, D. J. Unsworth, 2015, Postgraduate Medical Journal.

Hypogammaglobulinaemia with absent B lymphocytes and agranulocytosis after carbamazepine treatment.

M. Gompels, G. Spickett, P. Saunders, 1996, Journal of neurology, neurosurgery, and psychiatry.

Echocardiographic abnormalities in primary antibody deficiency

M. Gompels, J. Dwight, D. J. Unsworth, 2004, Postgraduate Medical Journal.

HIV Diagnosis at CD4 Count Above 500 Cells/mm3 and Progression to Below 350 Cells/mm3 Without Antiretroviral Therapy

Delpech, B. Gazzard, C. Leen, 2007, Journal of acquired immune deficiency syndromes.

Lymphoproliferative disease in antibody deficiency: a multi‐centre study

H. White, B. Angus, M. Gompels, 2003, Clinical and experimental immunology.

Treatment of EBV driven lymphoproliferation with erythrophagocytosis: 12 year follow up

B. Angus, M. Gompels, G. Spickett, 2001, Journal of clinical pathology.

First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines

A. Winston, C. Sabin, A. Phillips, 2020, AIDS.

A Family with a Novel CTLA4 Haploinsufficiency Mutation and Neurological Symptoms

M. Gompels, S. Johnston, A. Grammatikos, 2021, Journal of Clinical Immunology.

CNS demyelination associated with immune dysregulation and a novel CTLA-4 variant

S. Renowden, N. Patel, M. Gompels, 2020, Multiple sclerosis.

Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients.

M. Gompels, M. Shahmanesh, M. Huengsberg, 1998, Clinical chemistry.

Laboratory adverse events and discontinuation of therapy according to CD4+ cell count at the start of antiretroviral therapy

C. Leen, C. Sabin, M. Johnson, 2014, AIDS.

Disseminated pneumocystis carinii infection in AIDS.

R. Miller, J. Ainsworth, R. Coker, 1991, Journal of clinical pathology.

Antibiotic prophylaxis for the prevention of respiratory tract infections in antibody deficient patients: A retrospective cohort study

M. Gompels, S. Johnston, A. Grammatikos, 2020 .

The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations

C. Leen, A. Winston, C. Sabin, 2013, HIV medicine.

The wrong Spirochaete? Acute kidney injury in a returning traveller with syphilis – a case report

M. Gompels, Hannah E Cook, 2020, BMC Infectious Diseases.

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

R. Lockey, R. Pawankar, W. Aberer, 2022, The World Allergy Organization journal.

A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency.

M. Gompels, P. Virgo, R. J. Lock, 2002, Journal of clinical pathology.

C1-inhibitor deficiencies (hereditary angioedema): Where are we with therapies?

M. Gompels, R. J. Lock, 2007, Current allergy and asthma reports.

C1 inhibitor deficiency: diagnosis

M. Gompels, R. J. Lock, 2005, Clinical and experimental dermatology.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Hansjakob Furrer, Manuel Battegay, Pietro Vernazza, 2019, The Lancet.

HAE international home therapy consensus document

M. Gompels, H. Farkas, M. Levi, 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Predicting virological decay in patients starting combination antiretroviral therapy

J. Sterne, C. Leen, R. Gilson, 2016, AIDS.

Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS.

D Tomlinson, R. Coker, J. Harris, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Scedosporium apiospermum in chronic granulomatous disease treated with an HLA matched bone marrow transplant

M. Gompels, G. Jackson, C. Bethune, 2002, Journal of clinical pathology.

Late diagnosis in the HAART era: proposed common definitions and associations with mortality

B. Gazzard, C. Leen, C. Sabin, 2010, AIDS.

Misdiagnosis of hereditary angio‐oedema type 1 and type 2

M. Gompels, D. J. Unsworth, S. Johnston, 2003, The British journal of dermatology.

Initial presenting manifestations in 16,486 patients with Inborn Errors of Immunity include infections and non-infectious manifestations.

Nurit Assia Batzir, K. Schwarz, D. Foell, 2021, The Journal of allergy and clinical immunology.

Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfect

E. Beck, M. Gompels, E. Kupek, 1996, International journal of STD & AIDS.

Hepatitis E virus coinfection in patients with HIV infection

M. Gompels, S. Ijaz, R. Bendall, 2011, HIV medicine.

Hepatitis B, hepatitis C, and mortality among HIV-positive individuals

C. Leen, C. Sabin, M. Gompels, 2017, AIDS.

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV

B. Gazzard, C. Leen, C. Fraser, 2019, Journal of virus eradication.

Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression

C. Leen, C. Sabin, A. Phillips, 2014, AIDS.

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

Kholoud Porter, John Walsh, Martin Fisher, 2014, AIDS.

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial

A. Winston, M. Johnson, M. Gompels, 2015, The lancet. HIV.

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency

M. Triggiani, P. Schmid‐Grendelmeier, W. Aberer, 2016, Allergy.

Ondansetron Usage in HIV Positive Patients: A Pilot Study on the Control of Nausea and Vomiting in Patients on High Dose Co-Trimoxazole for Pneumocystis Carinii Pneumonia

J. Harris, M. Gompels, A. Pinching, 1993, International journal of STD & AIDS.

Surveillance study on the tolerability and safety of Flebogamma® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients

M. Gompels, L. Alsina, E. Drewe, 2017, Pharmacology research & perspectives.

Anaphylactic shock due to cefuroxime in a patient taking penicillin prophylaxis

M. Gompels, D. Prosser, 2002, Paediatric anaesthesia.

C1 inhibitor deficiency: 2014 United Kingdom consensus document

M. Gompels, S. Seneviratne, C. Cale, 2015, Clinical and experimental immunology.

Short title: 2014 UK HAE Consensus

M. Gompels, S. Seneviratne, C. Cale, 2014 .

Cinryze™ (C1-inhibitor) for the treatment of hereditary angioedema

M. Gompels, R. J. Lock, 2011, Expert review of clinical immunology.

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

M. Triggiani, W. Aberer, M. Gompels, 2018, The New England journal of medicine.

University of Southern Denmark Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema Aygören-Pürsün,

M. Triggiani, W. Aberer, M. Gompels, 2018 .

Takayasu arteritis: a review.

M. Gompels, S. Johnston, R. J. Lock, 2002, Journal of clinical pathology.

Adrenaline given outside the context of life threatening allergic reactions

M. Gompels, S. Johnston, J. Unsworth, 2003, BMJ : British Medical Journal.

Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS‐2 study

M. Triggiani, J. Bernstein, M. Gompels, 2018, Allergy.

Laboratory testing for C1 inhibitor deficiency: a comparison of two approaches to C1 inhibitor function

M. Gompels, R. J. Lock, 2007, Annals of clinical biochemistry.

Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence

Todor A Popov, T. Zuberbier, N. Papadopoulos, 2020, Allergy.

Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom

John P. Walsh, Andrew N. Phillips, Steve Kaye, 2007, AIDS.

Transmitted HIV‐1 drug resistance in a large international cohort using next‐generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study

M. Kozal, J. Lundgren, A. Tostevin, 2020, HIV medicine.

Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study

C. Sabin, M. Gompels, M. May, 2012, Journal of the International AIDS Society.

Mind the gap: difference between Framingham heart age and real age increases with age in HIV-positive individuals–a clinical cohort study

M. May, M. Gompels, S. Johnston, 2013, BMJ Open.

Outcomes in the First Year after Initiation of First-Line Haart among Heterosexual Men and Women in the Uk Chic Study

B. Gazzard, C. Leen, D. Pillay, 2011, Antiviral therapy.

Long‐term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study

C. Leen, D. Pillay, P. Easterbrook, 2011, HIV medicine.

A novel strategy to reduce very late HIV diagnosis in high-prevalence areas in South-West England: serious incident audit

J. Macleod, M. May, M. Gompels, 2016, Journal of public health.

Chronic fatigue, arthralgia, and malaise.

M. Gompels, G. Spickett, 1996, Annals of the rheumatic diseases.

A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study

C. Leen, D. Pillay, C. Sabin, 2018, The lancet. HIV.

Clinically significant depressive symptoms and sexual behaviour among men who have sex with men

A. Phillips, F. Lampe, A. Clarke, 2017, BJPsych Open.

Evidence of changing sexual behaviours and clinical attendance patterns, alongside increasing diagnoses of STIs in MSM and TPSM

M. Gompels, A. Lorenc, P. Muir, 2021, Sexually Transmitted Infections.

Development and application of a new measure of engagement in out‐patient HIV care

B. Gazzard, C. Leen, D. Pillay, 2016, HIV Medicine.

Subclinical hypothyroidism: a comparison of strategies to achieve adherence to treatment guidelines

M. Gompels, D. Goldie, R. J. Lock, 2004, Annals of clinical biochemistry.

A Cross-Sectional Study on Attitudes to and Understanding of Risk of Acquisition of HIV: Design, Methods and Participant Characteristics

A. Phillips, F. Lampe, A. Clarke, 2016, JMIR research protocols.

Dual therapy with renally adjusted lamivudine and dolutegravir: a switch strategy to manage comorbidity and toxicity in older, suppressed patients?

M. Gompels, S. Johnston, J. Nicholls, 2019, HIV medicine.

False interpretation of diagnostic serology tests for patients treated with pooled human immunoglobulin G infusions: a trap for the unwary.

M. Gompels, S. Johnston, J. Usher, 2015, Clinical medicine.

COVID-19 vaccine allergy advice and guidance: The experience of a UK tertiary referral centre

M. Gompels, F. Moghaddas, P. Bright, 2023, World Allergy Organization Journal.

Uptake and Outcome of Combination Antiretroviral Therapy in Men Who Have Sex with Men According to Ethnic Group: The UK CHIC Study

B. Gazzard, C. Leen, C. Sabin, 2011, Journal of acquired immune deficiency syndromes.

The use of funnel plots with regression as a tool to visually compare HIV treatment outcomes between centres adjusting for patient characteristics and size: a UK Collaborative HIV Cohort study

C. Sabin, M. May, M. Gompels, 2018, HIV medicine.

The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017

Smita Y. Patel, A. Gennery, A. Worth, 2018, Clinical and experimental immunology.

Evaluation of an educational intervention to increase HIV-testing in high HIV prevalence general practices: a pilot feasibility stepped-wedged randomised controlled trial

M. May, M. Gompels, J. Horwood, 2018, BMC Family Practice.

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk

H. Stellbrink, J. Gatell, M. Johnson, 2017, AIDS.

Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations *

C. Leen, C. Sabin, P. Easterbrook, 2010, HIV medicine.

Impact on life expectancy of late diagnosis and treatment of HIV-1 infected individuals: UK CHIC

C. Sabin, M. Gompels, M. May, 2010, Journal of the International AIDS Society.

Antiretroviral therapy CNS penetration and HIV-1–associated CNS disease

B. Gazzard, C. Leen, D. Pillay, 2011, Neurology.

Qualitative evaluation of a pilot educational intervention to increase primary care HIV-testing

M. May, M. Gompels, J. Horwood, 2019, BMC Family Practice.

Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study

C. Leen, D. Pillay, R. Gilson, 2017, The lancet. HIV.

Uveitis in a patient with common variable immunodeficiency

M. Gompels, R. Gray, J. Vodden, 2003, Eye.

CORRESPONDENCE

M. Gompels, J. Winer, R. Round, 1999, Neuroscience Letters.

Treatment Outcome and Cost-Effectiveness of Different Highly Active Antiretroviral Therapy Regimens in the Uk (1996–2002)

B. Gazzard, R. Brettle, M. Youle, 2008, International journal of STD & AIDS.

Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease.

D. Podzamczer, B. Clotet, A. Winston, 2020, The Journal of antimicrobial chemotherapy.

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation

B. Gazzard, D. Webster, C. Leen, 2015, HIV medicine.

Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir–Ritonavir Plus Either Raltegravir or Tenofovir–Emtricitabine: A Substudy of the NEAT001/ANRS143 Trial

H. Amièva, A. d’Arminio Monforte, A. Winston, 2017, Journal of acquired immune deficiency syndromes.

Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure

C. Leen, D. Pillay, R. Gilson, 2014, The Journal of infectious diseases.

Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?

B. Gazzard, C. Leen, D. Pillay, 2012, The Journal of infectious diseases.

Acute myeloblastic leukaemia in AIDS.

M. Gompels, B. Peters, A. Pinching, 1990, AIDS.

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

C. Leen, C. Fraser, E. Volz, 2018, The Journal of antimicrobial chemotherapy.

Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV.

M. Gompels, S. Glover, L. Howe, 2002, The Journal of infection.

Non‐uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK

B. Gazzard, C. Leen, J. Ainsworth, 2012, HIV medicine.

Successful oral treatment of Ganciclovir resistant cytomegalovirus with Maribavir in the context of primary immunodeficiency: First case report and review.

M. Gompels, S. Johnston, M. Donati, 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease

M. Gompels, Y. Gilleece, M. Nelson, 2023, PloS one.

Rising Population Cost for Treating People Living with HIV in the UK, 1997-2013

B. Gazzard, R. Brettle, M. Youle, 2010, PloS one.

Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring.

B. Gazzard, C. Leen, A. Winston, 2013, The Journal of antimicrobial chemotherapy.

Chronic Kidney Disease Risk in African and Caribbean Populations With HIV

B. Gazzard, C. Leen, D. Pillay, 2018, The Journal of infectious diseases.

Benchmarked performance charts using principal components analysis to improve the effectiveness of feedback for audit data in HIV care

C. Sabin, M. May, M. Gompels, 2017, BMC Health Services Research.

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

B. Gazzard, D. Webster, C. Leen, 2013, The Journal of antimicrobial chemotherapy.

Chronic or recurrent Campylobacter enteritis in primary immunodeficiency: a UK national case-series and review of the literature.

M. Gompels, S. Johnston, S. Grigoriadou, 2023, The journal of allergy and clinical immunology. In practice.

Hyper‐IgM syndrome resulting from heterozygous AICDA variants: A European first?

M. Gompels, G. Arumugakani, S. Savic, 2022, Scandinavian journal of immunology.

Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

M. Triggiani, W. Aberer, R. Perricone, 2012, Allergy.

Rate of response to initial antiretroviral therapy according to level of pre-existing HIV-1 drug resistance detected by next-generation sequencing in the strategic timing of antiretroviral treatment (START) study.

M. Kozal, A. Tostevin, M. Gompels, 2023, HIV medicine.

Serum cysteine levels in HIV infection.

M. Gompels, M. Shahmanesh, M. Huengsberg, 1998, AIDS.

Smita Y. Patel, A. Nicholson, D. Rassl, 2017, The journal of allergy and clinical immunology. In practice.

emergency posts senior house officers starting accident and anaphylaxis and related conditions: a study of Proposed use of adrenaline (epinephrine) in

M. Gompels, S. Johnston, C. Bethune, 2005 .

Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT Trial

M. Gompels, A. Arenas-Pinto, Amanda Clarke, 2023, Viruses.

The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996 – 2008

R. Brettle, M. Youle, E. Beck, 2012 .

Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema

M. Triggiani, W. Aberer, M. Gompels, 2018, The New England journal of medicine.

Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation

Andrew L. Kerr, C. Leen, C. Fraser, 2020, HIV medicine.